Trimetazidine tablet bulk supplier for pharma manufacturers

Trimetazidine Tablet 20 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 20 mg

Reference Brands: Vazocardin(EU)

Trimetazidine improves cardiac metabolism by shifting energy production from fatty acids to glucose, increasing efficiency during ischemic stress. It reduces angina symptoms, enhances exercise tolerance, and protects heart tissue. Benefits include decreased angina frequency, better blood flow, reduced myocardial injury, and improved quality of life in ischemic heart disease patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Trimetazidine tablets, marketed as Vazocardin, are approved in the EU for angina and ischemic heart disease but are not approved in the US. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the EU, the EMA reviews detailed clinical trial data and ensures compliance with regional safety standards. In the US, the FDA has not authorized trimetazidine for sale, citing safety concerns. For guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and worldwide availability, helping to optimize treatment for ischemic heart conditions.

Trimetazidine Tablet — third party manufacturing & bulk supply

Trimetazidine Tablet 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Trimetazidine Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Trimetazidine Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Trimetazidine Tablet →

Back to Listing

Frequently Asked Questions

Trimetazidine tablet is listed as Tablet in 20 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Trimetazidine tablet is referenced against Vazocardin(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.